Benzinga | May 6, 2021 04:43PM EDT

Coherus BioSciences Q1 EPS $0.01 Misses $0.06 Estimate, Sales $83.03M Miss $96.00M Estimate

Coherus BioSciences (NASDAQ:CHRS) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.06 by 83.33 percent. This is a 97.92 percent decrease over earnings of $0.48 per share from the same period last year. The company reported quarterly sales of $83.03 million which missed the analyst consensus estimate of $96.00 million by 13.51 percent. This is a 28.53 percent decrease over sales of $116.18 million the same period last year.